Agenda for Pre-Conference Workshops – Monday, March 22, 2027 - EST/EDT (Eastern Daylight, GMT-4)
Analyze the status of MFN policy proposals and their potential implementation timeline
Examine the GLOBE Model (Global Benchmark for Efficient Drug Pricing) and its impact on Medicare Part B drug pricing
Analyze the GUARD Model and its implications for patient access and rare disease therapies
Compare and contrast MFN, GLOBE, and GUARD approaches, including key differences, overlap and combined impact on the market
Address strategies to maintain patient access amid evolving international pricing benchmarks
Examine the five-year performance period implications for long-term patient support planning
- Max Bronstein - Founder, CEO, Aviva Strategies
- Samantha Gilman - Director, Public Affairs, Servier
Navigate the sweeping changes from the One Big Beautiful Bill Act affecting Medicaid and Medicare
Master strategies for serving dual-eligible populations amid increased redetermination frequency and eligibility restrictions
Address the impact of retroactive coverage limitations on patient enrollment and support
Explore the $35 copay per service requirement for some Medicaid enrollees (effective October 2028) and early preparation strategies
Examine the second wave of Medicare drug price negotiations and their impact on patient assistance program design
Understand how the increased $2,400 out-of-pocket cap affects patient affordability and program eligibility
Navigate the evolving landscape of negotiated Maximum Fair Prices (MFPs) and their implications for patient support services
Adapt copay assistance and patient support programs to align with Part D benefit restructuring
- Mallory O’Connor - Executive Director, Public Policy, Keenova Therapeutics
Participate in facilitated roundtable discussions with industry peers navigating the same policy implementation challenges
Share real-world experiences from the first weeks of January 2027 policy rollouts – what's working, what's failing and what surprised your organization
Crowdsource strategies for addressing dual-eligible patient disruptions, IRA negotiation impacts and preparing for international reference pricing implementation
Develop action items and cross-policy mitigation plans based on peer insights and workshop learnings
- Samantha Gilman - Director, Public Affairs, Servier
